Metastasis ability, genomic profile, subtype characteristic and curative efficacy of multiple pulmonary hematogenous metastases in lung cancer

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Liuer He, Xin Nie, Jiayi Gao, Yue Yuan, Xue Wang, Xu Li, Fengzhu Guo, Min Tang, Ping Zhang, Lin Li
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Clinical and Translational Medicine
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
par: Bing Feng, et autres
Publié: (2024)

Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study
par: Pulin Li, et autres
Publié: (2024)

Illuminating the genomic frontier of invasive non‐typhoidal Salmonella infections
par: Hao Wang, et autres
Publié: (2025)

Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation
par: Jie Huang, et autres
Publié: (2024)

Multi‐omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited‐stage small cell lung cancer to definitive chemoradiotherapy
par: Li Li, et autres
Publié: (2024)

Genomic classification of intrapulmonary metastasis and multiple primary lung cancer
par: Jeongsoo Won, et autres
Publié: (2025)

Prognosis‐oriented molecular subtypes of retroperitoneal liposarcoma
par: Mengmeng Xiao, et autres
Publié: (2024)

FTO‐mediated m6A demethylation regulates IGFBP3 expression and AKT activation through IMP3‐dependent P‐body re‐localisation in lung cancer
par: Haiyang Wang, et autres
Publié: (2025)

Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma
par: Linshan Xie, et autres
Publié: (2024)

Distinct discrepancy in breast cancer organoids recapitulation among molecular subtypes revealed by single‐cell transcriptomes analysis
par: Ziqi Jia, et autres
Publié: (2024)

Spatial transcriptomic analysis across histological subtypes reveals molecular heterogeneity and prognostic markers in early‐stage lung adenocarcinoma
par: Hua Geng, et autres
Publié: (2025)

Longitudinal circulating tumour DNA dynamics predict failure patterns and efficacy of consolidation immunotherapy after chemoradiotherapy in locally advanced non‐small‐cell lung cancer
par: Yu Wang, et autres
Publié: (2024)

Single‐cell dissection reveals immunosuppressive F13A1+ macrophage as a hallmark for multiple primary lung cancers
par: Chenglin Yang, et autres
Publié: (2024)

Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non‐small‐cell lung cancer
par: Ke Xu, et autres
Publié: (2024)

Persistent lineage plasticity driving lung cancer development and progression
par: Fanchen Meng, et autres
Publié: (2025)

Engineered lung cell targeting and SLC7A11 siRNA expressing bacterial extracellular vesicles impair the progression of none‐small cell lung cancer
par: Xiao‐dan Wan, et autres
Publié: (2025)

Improving detection of colorectal cancer: A Bayesian approach to serial circulating tumour DNA testing following curative‐intent treatment.
par: Susanne K. Pedersen, et autres
Publié: (2026)

The co‐location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non‐small cell lung cancer
par: Guangyu Fan, et autres
Publié: (2024)

Cell‐free epigenomes enhanced fragmentomics‐based model for early detection of lung cancer
par: Yadong Wang, et autres
Publié: (2025)

Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma
par: Shuai Yang, et autres
Publié: (2024)

5‐hydroxymethylcytosine features of portal venous blood predict metachronous liver metastases of colorectal cancer and reveal phosphodiesterase 4 as a therapeutic target
par: Nuo Xu, et autres
Publié: (2025)

A subtype of cancer‐associated fibroblast expressing syndecan‐2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer
par: Ji‐Yong Sung, et autres
Publié: (2024)

Prediction of clinical risk assessment and survival in chronic obstructive pulmonary disease with pulmonary hypertension
par: Dansha Zhou, et autres
Publié: (2024)

Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity
par: Beata Szeitz, et autres
Publié: (2025)

LcProt: Proteomics‐based identification of plasma biomarkers for lung cancer multievent, a multicentre study
par: Hengrui Liang, et autres
Publié: (2025)

Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies
par: Xuwen Lin, et autres
Publié: (2024)

Bidirectional crosstalk between cancer cells and cancer‐associated fibroblasts in mixed organoid system elicits transcriptomic characteristics of pancreatic cancer with potential therapeutic vulnerabilities
par: Jae‐Il Choi, et autres
Publié: (2024)

Comprehensive genomic analysis of molecular residual disease based on circulating tumour DNA in postoperative patients with colorectal cancer
par: Qingqi Hong, et autres
Publié: (2024)

Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer
par: Sally E. Claridge, et autres
Publié: (2025)

Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer
par: Haoran Li, et autres
Publié: (2024)

Multi‐omics molecular phenotyping reveals the potential mechanisms of chemotherapy response and resistance in small cell lung cancer
par: Ying Cheng, et autres
Publié: (2024)

Integrative single‐cell transcriptomic analysis deciphers heterogeneous characteristics of gastrointestinal tract cancer
par: Chuwen Sun, et autres
Publié: (2025)

Translational inhalable extracellular vesicle‐based mRNA therapy for the treatment of lung cancer
par: Mengrui Liu, et autres
Publié: (2025)

Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
par: Jacob E. Till, et autres
Publié: (2026)

Genome‐wide profiling of N6‐methyladenosine‐modified pseudogene‐derived long noncoding RNAs reveals the tumour‐promoting and innate immune‐restraining function of RPS15AP12 in ovarian cancer
par: Jie Xu, et autres
Publié: (2025)

Granulocyte colony‐stimulating factor induced T‐cell hyporesponsiveness via modulation of CD177 + S100A hi neutrophils in unexplained recurrent pregnancy loss
par: Ping‐Fen Li, et autres
Publié: (2025)

Baseline multi‐omics signatures could predict therapeutic response to neoadjuvant anti‐PD‐1 immunochemotherapy in non‐small‐cell lung cancer
par: Ailing Cao, et autres
Publié: (2026)

O‐GlcNAcylation promotes malignancy and cisplatin resistance of lung cancer by stabilising NRF2
par: Yihan Zhang, et autres
Publié: (2024)

Validation and depth evaluation of recurrent neural network‐based ultra low‐pass genome sequencing for the detection of absence of heterozygosity: A multi‐centre study of 409 cases
par: Yeqing Qian, et autres
Publié: (2024)

Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer
par: Yifan Cao, et autres
Publié: (2024)